SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

AGM Statement

26 Jun 2017 07:00

RNS Number : 0781J
Warpaint London PLC
26 June 2017
 

26 June 2017

Warpaint London plc

("Warpaint London" or the "Company" or the "Group")

AGM Statement

 

At the Annual General Meeting of Warpaint London plc (AIM: W7L) to be held later today, Clive Garston, Chairman of the Company, will make the following statement:

"I am pleased to report that the Company continues to trade in line with expectations. So far in 2017, we have seen encouraging growth across all our sales territories worldwide, apart from Europe where sales remain similar to the corresponding period in 2016. I am particularly pleased that our sales strategy for the US, which is the world's largest colour cosmetics market, has delivered double-digit sales growth compared to the same period last year.

We recently launched our new Very Vegan range of products and early sales, whilst modest in the context of the Group, have been encouraging. We will continue to innovate and look for further opportunities to introduce new products into our mix.

Our E-commerce strategy remains on track and is a growing contributor to the Group. Supported by celebrity endorsements, particularly through social media, we expect the importance of on-line sales to continue to grow.

I am pleased with the performance of the Group since admission to AIM in November last year. Being quoted on AIM has been a positive experience for the Company, in particular helping the recognition and development of the W7 brand globally.

We look forward to updating the market at the time of the release of our interim results in September 2017."

 

Enquiries:

Warpaint London plc

Sam Bazini - Joint Chief Executive

Eoin Macleod - Joint Chief Executive

Neil Rodol - Chief Financial Officer

 

020 3053 8671

 

Stockdale Securities Limited (Nominated Adviser and Broker)

Andy Crossley, Antonio Bossi, Ed Thomas - Corporate Finance

Fiona Conroy - Corporate Broking

 

020 7601 6100

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

Miles Nolan

020 3053 8671

 

 

About Warpaint London plc

Warpaint London is a colour cosmetics business, based in Iver, Buckinghamshire. It is made up of two divisions: close-out and own-brand. The second and larger own-brand division consists primarily of the Group's flagship brand, W7 - an extremely creative, design-focused cosmetic brand proposition with a focus on the 16-30 age range, delivering high-quality cosmetics at affordable prices. W7 brand has grown organically since its inception in 2002 and now contains over 500 items which are sold into high street retailers and independent beauty shops across the UK, Europe, Australia and the US. In 2016, W7 was supplied to over 250 customers in more than 50 countries.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMOKPDBFBKKDAB
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM and Posting of Annual Report
29th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSNotice of Results
9th Apr 20269:41 amRNSBlock Listing Return
17th Feb 20261:34 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSRule 19.6(c) confirmation re Brand Architekts
9th Feb 20262:21 pmRNSCompletion of the acquisition of the Barry M brand
9th Feb 20267:00 amRNSAcquisition of Barry M brand & FY25 Trading Update
24th Nov 202512:16 pmRNSHolding(s) in Company
10th Nov 20252:06 pmRNSBLOCK LISTING RETURN
29th Oct 20252:52 pmRNSHolding(s) in Company
9th Oct 20251:36 pmRNSBlock listing Return
8th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
17th Sep 20259:12 amRNSHolding(s) in Company
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Results
21st Aug 20252:23 pmRNSHolding(s) in Company
19th Aug 20258:21 amRNSHolding(s) in Company
17th Jun 202510:46 amRNSResult of AGM
17th Jun 20257:00 amRNSAGM Statement
28th May 20252:43 pmRNSHolding(s) in Company
20th May 202512:01 pmRNSHolding(s) in Company
20th May 20257:30 amRNSNotice of AGM and Posting of Annual Report
13th May 20254:54 pmRNSBlock listing Interim Return
29th Apr 20257:00 amRNSResults for the year ended 31 December 2024
14th Apr 20257:00 amRNSNotice of Results
9th Apr 20253:07 pmRNSBLOCK LISTING RETURN
24th Mar 20251:38 pmRNSAnnouncement pursuant to AIM rule 13
13th Feb 20253:18 pmGNWForm 8.3 - Warpaint London Plc
13th Feb 20251:52 pmRNSForm 8.3 - Warpaint London plc
13th Feb 202512:17 pmRNSForm 8.3 - Warpaint London Plc
13th Feb 202511:50 amRNSForm 8.5 (EPT/RI)
13th Feb 202511:24 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
12th Feb 20255:56 pmRNSForm 8.3 - Warpaint London plc Amend
12th Feb 20253:46 pmRNSDirector/PDMR Dealing
12th Feb 20253:37 pmRNSApplication for Admission of Shares and TVR
12th Feb 20253:25 pmRNSReplacement: Scheme Effective
12th Feb 20253:10 pmRNSForm 8.3 - Warpaint London plc
12th Feb 20252:41 pmGNWForm 8.3 - Warpaint London Plc
12th Feb 20252:19 pmRNSForm 8.3 - Warpaint London Plc
12th Feb 202512:05 pmPRNForm 8.3 - Warpaint London Plc
12th Feb 202511:48 amRNSForm 8.3 - Warpaint London plc
12th Feb 202511:35 amRNSForm 8.3 - Warpaint London PLC
12th Feb 202510:59 amRNSForm 8.5 (EPT/RI)
12th Feb 202510:54 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 20253:04 pmGNWForm 8.3 - Warpaint London Plc
11th Feb 202512:19 pmRNSForm 8.3 - Warpaint London plc
11th Feb 202511:03 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
11th Feb 202510:49 amRNSForm 8.5 (EPT/RI)
11th Feb 202510:36 amRNSForm 8.3 - Warpaint London plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.